Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study.
García-García I, González-Delgado CA, Valenzuela-Silva CM, Díaz-Machado A, Cruz-Díaz M, Nodarse-Cuní H, Pérez-Pérez O, Bermúdez-Badell CH, Ferrero-Bibilonia J, Páez-Meireles R, Bello-Rivero I, Castro-Odio FR, López-Saura PA; FarmaPEG Study Group. García-García I, et al. Among authors: lopez saura pa. BMC Pharmacol. 2010 Nov 23;10:15. doi: 10.1186/1471-2210-10-15. BMC Pharmacol. 2010. PMID: 21092287 Free PMC article. Clinical Trial.
Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers.
García-García I, Hernández-González I, Díaz-Machado A, González-Delgado CA, Pérez-Rodríguez S, García-Vega Y, Campos-Mojena R, Tuero-Iglesias ÁD, Valenzuela-Silva CM, Cruz-Ramírez A, Martín-Trujillo A, Santana-Milián H, López-Saura PA, Bello-Rivero I; CIGB-128-A Study Group. García-García I, et al. Among authors: lopez saura pa. BMC Pharmacol Toxicol. 2016 Dec 7;17(1):58. doi: 10.1186/s40360-016-0103-8. BMC Pharmacol Toxicol. 2016. PMID: 27923408 Free PMC article. Clinical Trial.
Bioequivalence of two recombinant granulocyte colony-stimulating factor formulations in healthy male volunteers.
Hernández-Bernal F, García-García I, González-Delgado CA, Valenzuela-Silva C, Soto-Hernández R, Ducongé J, Cervantes-Llano M, Blanco-Garcés E, Rodríguez V, García-Vega Y, Bello-Rivero I, Olivera-Ruano L, López-Saura P. Hernández-Bernal F, et al. Biopharm Drug Dispos. 2005 May;26(4):151-9. doi: 10.1002/bdd.445. Biopharm Drug Dispos. 2005. PMID: 15799006 Clinical Trial.
Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
Pérez-Oliva JF, Casanova-González M, García-García I, Porrero-Martín PJ, Valenzuela-Silva CM, Hernández-Montero T, Lagarde-Ampudia M, Casanova-Kutsareva Y, Avila-Albuerne Y, Vargas-Batista A, Bobillo-López H, Herrera-Valdés R, López-Saura PA; Bioequivalence Study of Erythropoietin Group. Pérez-Oliva JF, et al. BMC Nephrol. 2005 May 23;6:5. doi: 10.1186/1471-2369-6-5. BMC Nephrol. 2005. PMID: 15910687 Free PMC article. Clinical Trial.
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.
Betancourt BY, Marrero-Miragaya MA, Jiménez-López G, Valenzuela-Silva C, García-Iglesias E, Hernández-Bernal F, Debesa-García F, González-López T, Alvarez-Falcón L, López-Saura PA; Cuban National Network of Pharmacoepidemiology. Betancourt BY, et al. BMC Clin Pharmacol. 2005 Nov 2;5:5. doi: 10.1186/1472-6904-5-5. BMC Clin Pharmacol. 2005. PMID: 16262910 Free PMC article.
Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study.
Milanés-Virelles MT, García-García I, Santos-Herrera Y, Valdés-Quintana M, Valenzuela-Silva CM, Jiménez-Madrigal G, Ramos-Gómez TI, Bello-Rivero I, Fernández-Olivera N, Sánchez-de la Osa RB, Rodríguez-Acosta C, González-Méndez L, Martínez-Sánchez G, López-Saura PA; MACGAM Study Group. Milanés-Virelles MT, et al. BMC Infect Dis. 2008 Feb 11;8:17. doi: 10.1186/1471-2334-8-17. BMC Infect Dis. 2008. PMID: 18267006 Free PMC article. Clinical Trial.
Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers.
Yera-Alos IB, Alonso-Carbonell L, Valenzuela-Silva CM, Tuero-Iglesias AD, Moreira-Martínez M, Marrero-Rodríguez I, López-Mola E, López-Saura PA. Yera-Alos IB, et al. Among authors: lopez saura pa. BMC Pharmacol Toxicol. 2013 Sep 3;14:44. doi: 10.1186/2050-6511-14-44. BMC Pharmacol Toxicol. 2013. PMID: 24004460 Free PMC article.
66 results